Eli Lilly to Offer Breakthrough Migraine Drug for Free
*By Michael Teich*
[Twelve percent](https://migraineresearchfoundation.org/about-migraine/migraine-facts/) of the U.S. population may suffer from chronic migraines, but many Americans don't appreciate the impact, said president of Lilly Bio-Medicines Christi Shaw.
"These patients need to be treated seriously. This is a neurological disorder," Shaw said Friday in an interview on Cheddar.
Eli Lilly ($LLY) just received clearance from the FDA for its latest drug, and it could change the lives of the 39 million Americans suffering from migraines, according to Shaw.
The treatment, Emgality, is a monthly, self-administered injection that will help patients cut the frequency of their migraines in half, she said.
Shaw said that many Americans conflate headaches and migraines, and so they often dismiss their pain. They key difference is that the symptoms of a migraine disrupt one's ability to function optimally through the day. That doesn't happen with a more commonplace headache. And a stigma contributes to the glaring statistic that only about 10 percent of those suffering from migraines take prescription drugs for prevention, Shaw said.
Emgality comes with a serious price tag: $6,900 a year, or $575 a month. But Eli Lilly is offering commercially insured patients up to 12 months of the drug for free. It's among the latest efforts from the industry to offer consumers some relief from surging drug costs.
Competitors Amgen ($AMGN) and Teva ($TEVA) have already unveiled new migraine treatment drugs.
For full interview [click here](https://cheddar.com/videos/eli-lilly-gets-fda-approval-for-new-migraine-treatment).
Heavy rainfall flooded parts of Massachusetts and Rhode Island, with two communities declaring a state of emergency as water poured into homes, creating moats around their foundations and leading to boat rescues of residents. Concern about a dam listed in poor condition led to more evacuations.
The leading decongestant used by millions of Americans looking for relief from a stuffy nose is no better than a dummy pill, according to government experts who reviewed the latest research on the long-questioned drug ingredient.
Hurricane Lee, still a Category 3 storm with winds of 115 mph, is expected to increase in size but be significantly weaker in the coming days, as it turns north to reach the U.S. East Coast, according to the National Hurricane Center.
The U.S. approved updated COVID-19 vaccines Monday, hoping to rev up protection against the latest coronavirus strains and blunt any surge this fall and winter.
An earthquake has sown destruction and devastation in Morocco, where death and injury counts continue to rise as rescue crews dig out people both alive and dead in villages that were reduced to rubble.
Hurricane Lee whipped up waves of more than 15 feet (5 meters) on Monday as the Category 3 storm cranked through open waters just north of the Caribbean region.
